These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32436214)

  • 1. Transgenic LQT2, LQT5, and LQT2-5 rabbit models with decreased repolarisation reserve for prediction of drug-induced ventricular arrhythmias.
    Hornyik T; Castiglione A; Franke G; Perez-Feliz S; Major P; Hiripi L; Koren G; Bősze Z; Varró A; Zehender M; Brunner M; Bode C; Baczkó I; Odening KE
    Br J Pharmacol; 2020 Aug; 177(16):3744-3759. PubMed ID: 32436214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docosahexaenoic acid normalizes QT interval in long QT type 2 transgenic rabbit models in a genotype-specific fashion.
    Castiglione A; Hornyik T; Wülfers EM; Giammarino L; Edler I; Jowais JJ; Rieder M; Perez-Feliz S; Koren G; Bősze Z; Varró A; Zehender M; Brunner M; Bode C; Liin SI; Larsson HP; Baczkó I; Odening KE
    Europace; 2022 Mar; 24(3):511-522. PubMed ID: 34601592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel transgenic rabbit model with reduced repolarization reserve: long QT syndrome caused by a dominant-negative mutation of the KCNE1 gene.
    Major P; Baczkó I; Hiripi L; Odening KE; Juhász V; Kohajda Z; Horváth A; Seprényi G; Kovács M; Virág L; Jost N; Prorok J; Ördög B; Doleschall Z; Nattel S; Varró A; Bősze Z
    Br J Pharmacol; 2016 Jun; 173(12):2046-61. PubMed ID: 27076034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum hormones oxytocin and prolactin cause pro-arrhythmic prolongation of cardiac repolarization in long QT syndrome type 2.
    Bodi I; Sorge J; Castiglione A; Glatz SM; Wuelfers EM; Franke G; Perez-Feliz S; Koren G; Zehender M; Bugger H; Seemann G; Brunner M; Bode C; Odening KE
    Europace; 2019 Jul; 21(7):1126-1138. PubMed ID: 30938413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization.
    Odening KE; Hyder O; Chaves L; Schofield L; Brunner M; Kirk M; Zehender M; Peng X; Koren G
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2264-72. PubMed ID: 18835916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits.
    Odening KE; Jung BA; Lang CN; Cabrera Lozoya R; Ziupa D; Menza M; Relan J; Franke G; Perez Feliz S; Koren G; Zehender M; Bode C; Brunner M; Sermesant M; Föll D
    Heart Rhythm; 2013 Oct; 10(10):1533-41. PubMed ID: 23892340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computational analysis of the effect of sevoflurane in a human ventricular cell model of long QT syndrome: Importance of repolarization reserve in the QT-prolonging effect of sevoflurane.
    Kojima A; Fukushima Y; Itoh H; Imoto K; Matsuura H
    Eur J Pharmacol; 2020 Sep; 883():173378. PubMed ID: 32710951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome.
    Brunner M; Peng X; Liu GX; Ren XQ; Ziv O; Choi BR; Mathur R; Hajjiri M; Odening KE; Steinberg E; Folco EJ; Pringa E; Centracchio J; Macharzina RR; Donahay T; Schofield L; Rana N; Kirk M; Mitchell GF; Poppas A; Zehender M; Koren G
    J Clin Invest; 2008 Jun; 118(6):2246-59. PubMed ID: 18464931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Screening of Kv7.1 and Kv7.1/KCNE1 Activators as Potential Antiarrhythmic Drugs in the Zebrafish Heart.
    De la Cruz A; Wu X; Rainer QC; Hiniesto-Iñigo I; Perez ME; Edler I; Liin SI; Larsson HP
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2.
    Giannetti F; Barbieri M; Shiti A; Casini S; Sager PT; Das S; Pradhananga S; Srinivasan D; Nimani S; Alerni N; Louradour J; Mura M; Gnecchi M; Brink P; Zehender M; Koren G; Zaza A; Crotti L; Wilde AAM; Schwartz PJ; Remme CA; Gepstein L; Sala L; Odening KE
    Europace; 2023 May; 25(5):. PubMed ID: 37099628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility.
    Odening KE; Bodi I; Franke G; Rieke R; Ryan de Medeiros A; Perez-Feliz S; Fürniss H; Mettke L; Michaelides K; Lang CN; Steinfurt J; Pantulu ND; Ziupa D; Menza M; Zehender M; Bugger H; Peyronnet R; Behrends JC; Doleschall Z; Zur Hausen A; Bode C; Jolivet G; Brunner M
    Eur Heart J; 2019 Mar; 40(10):842-853. PubMed ID: 30496390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of the long QT syndrome: impact on management.
    Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice.
    Babij P; Askew GR; Nieuwenhuijsen B; Su CM; Bridal TR; Jow B; Argentieri TM; Kulik J; DeGennaro LJ; Spinelli W; Colatsky TJ
    Circ Res; 1998 Sep; 83(6):668-78. PubMed ID: 9742063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular genetics in the hereditary form of long QT syndrome].
    Georgijević Milić L
    Med Pregl; 2000; 53(1-2):51-4. PubMed ID: 10953551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological rescue of specific long QT variants of KCNQ1/KCNE1 channels.
    Zou X; Wu X; Sampson KJ; Colecraft HM; Larsson HP; Kass RS
    Front Physiol; 2022; 13():902224. PubMed ID: 36505078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Possible Explanation for the Low Penetrance of Pathogenic KCNE1 Variants in Long QT Syndrome Type 5.
    Déri S; Hartai T; Virág L; Jost N; Labro AJ; Varró A; Baczkó I; Nattel S; Ördög B
    Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
    Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin exerts harmful cardiac repolarization prolonging effects in drug-induced LQTS.
    Kreifels P; Bodi I; Hornyik T; Franke G; Perez-Feliz S; Lewetag R; Moss R; Castiglione A; Ziupa D; Zehender M; Brunner M; Bode C; Odening KE
    Int J Cardiol Heart Vasc; 2022 Jun; 40():101001. PubMed ID: 35391783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies with beta-adrenergic activity from chronic chagasic patients induce cardiac arrhythmias and early afterdepolarization in a drug-induced LQT2 rabbit hearts.
    Jiménez MAV; Nascimento JHM; Monnerat G; Maciel L; Paiva CN; Pedrosa RC; Campos de Carvalho AC; Medei E
    Int J Cardiol; 2017 Aug; 240():354-359. PubMed ID: 28320606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.